脓毒症休克早期相关血小板减少的危险因素及其对预后的影响
该回顾性研究纳入486例脓毒症休克患者,按使用血管活性药物24小时内最低血小板计数分为正常组(>100×10⁹/L,n=288)、轻度减少组(50-100×10⁹/L,n=123)和重度减少组(<50×10⁹/L,n=75)。糖尿病、尿路感染、G-杆菌感染、高乳酸血症和高APACHE II评分是血小板<50×10⁹/L的独立危险因素,腹部感染和髙SOFA评分是血小板≤100×10⁹/L的独立危险因素。三组机械通气时间、ICU住院时间和总住院时间无显著差异,但28天死亡率随血小板减少严重程度递增(重度66.7%、轻度43.1%、正常27.8%)。早期血小板减少提示脓毒症休克患者28天死亡高风险。
要点
- 脓毒症休克使用血管活性药物24小时内血小板<50×10⁹/L者28天死亡率为66.7%(50/75),显著高于血小板正常组的27.8%(80/288)。
- 血小板50-100×10⁹/L者28天死亡率为43.1%(53/123),亦显著高于正常血小板组。
- 糖尿病(OR=0.19)、尿路感染(OR=0.33)、G-杆菌感染(OR=0.20)、高乳酸血症(OR=1.25)和高APACHE II评分(OR=0.85)是血小板<50×10⁹/L的独立危险因素。
- 腹部感染是血小板50-100×10⁹/L的独立危险因素(OR=0.56),高SOFA评分是血小板≤100×10⁹/L的独立危险因素(<50×10⁹/L:OR=2.03;50-100×10⁹/L:OR=1.31)。
- 三组机械通气时间、ICU住院时间和住院时间无显著差异(P均>0.05),但28天生存率随血小板下降而降低(Log-Rank χ²=80.667,P<0.001)。
适用人群与场景
- 2016年6月至2020年11月苏北人民医院ICU收治的脓毒症休克患者,共486例。
- 按使用血管活性药物24小时内最低血小板计数分组:轻度减少组(50-100×10⁹/L,n=123)、重度减少组(<50×10⁹/L,n=75)、正常组(>100×10⁹/L,n=288)。
诊断标准与关键阈值
- 早期脓毒症休克相关血小板减少定义:使用血管活性药物24小时内最低血小板计数<100×10⁹/L。
- 严重程度分层:轻度50-100×10⁹/L,重度<50×10⁹/L,正常>100×10⁹/L。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 脓毒症休克使用血管活性药物24小时内出现血小板<50×10⁹/L提示28天死亡高风险(死亡率66.7%)。
- 血小板50-100×10⁹/L者28天死亡率亦达43.1%,需警惕预后恶化。
研究设计与关键结果
- 回顾性分析486例脓毒症休克患者,比较三组一般信息、实验室指标、机械通气时间、ICU住院时间、住院时间和28天死亡率。
- 血小板<50×10⁹/L的独立危险因素:糖尿病(OR=0.19,95%CI 0.08-0.42,P<0.001)、尿路感染(OR=0.33,95%CI 0.13-0.83,P=0.018)、G-杆菌感染(OR=0.20,95%CI 0.07-0.58,P=0.003)、高乳酸血症(OR=1.25,95%CI 1.07-1.46,P=0.005)、高APACHE II评分(OR=0.85,95%CI 0.78-0.92,P<0.001)。
- 血小板50-100×10⁹/L的独立危险因素:腹部感染(OR=0.56,95%CI 0.34-0.95,P=0.03)、高SOFA评分(OR=1.31,95%CI 1.16-1.48,P<0.001)。
- 血小板<50×10⁹/L的独立危险因素还包括高SOFA评分(OR=2.03,95%CI 1.65-2.52,P<0.001)。
- 三组机械通气时间、ICU住院时间和住院时间无显著差异(H值分别为0.142、2.134、3.990,P均>0.05)。
- 28天死亡率:重度减少组66.7%(50/75),轻度减少组43.1%(53/123),正常组27.8%(80/288),组间比较χ²=40.406,P<0.001;重度与轻度组均显著高于正常组(P均<0.05)。
- Kaplan-Meier生存曲线显示28天生存率随血小板下降而降低(Log-Rank χ²=80.667,P<0.001)。
证据类型、等级与局限
- 研究类型:单中心回顾性分析。
- 局限:单中心、回顾性设计,样本量486例,未提及盲法或前瞻性验证。
对床旁实践的改变
- 对脓毒症休克患者,使用血管活性药物后24小时内应关注血小板计数,血小板<50×10⁹/L提示28天死亡高风险。
- 合并糖尿病、尿路感染、G-杆菌感染、高乳酸血症或高APACHE II评分的脓毒症休克患者,发生重度血小板减少风险更高,需加强监测。
- 合并腹部感染或高SOFA评分者需警惕轻中度血小板减少。
- 原文未提及针对血小板减少的特殊治疗措施,不能从本文推出输血阈值或干预方案。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the risk factors and prognosis of early septic shock-related thrombocytopenia.
METHODS: Retrospective analysis of clinical data of patients with septic shock admitted to the department of intensive care unit (ICU) of Northern Jiangsu People's Hospital from June 2016 to November 2020 was conducted. According to the lowest platelet count (PLT) in the early stage of septic shock (within 24 hours of using vasoactive drugs), the patients were divided into mild thrombocytopenia group [PLT (50-100)×109/L], severe thrombocytopenia group (PLT < 50×109/L) and normal platelet group (PLT > 100×109/L). The differences in general information, laboratory indicators, mechanical ventilation time, length of ICU stay, in-hospital stay, and 28-day mortality among the three groups were analyzed. Multivariate Logistic regression was used to analyze the influencing factors of thrombocytopenia, and the 28-day Kaplan-Meier survival curve of patients with different PLT levels was drawn.
RESULTS: A total of 486 patients with septic shock were enrolled, including 123 patients with mild thrombocytopenia, 75 patients with severe thrombocytopenia and 288 patients with normal platelets. Patients with diabetes (χ2 = 30.460, P < 0.001), abdominal infection (χ2 = 15.024, P = 0.001), urinary tract infection (χ2 = 36.633, P < 0.001), bloodstream infection (χ2 = 7.755, P = 0.022), Gram negative (G-) bacilli infection (χ2 = 19.569, P < 0.001), hyperlactic acidemia (H = 23.404, P < 0.001), elevated procalcitonin (PCT, H = 43.368, P < 0.001), high acute physiology and chronic health evaluation II (APACHE II, F = 11.122, P < 0.001) and high sequential organ failure assessment (SOFA, F = 84.328, P < 0.001) were more likely to have thrombocytopenia within 24 hours of septic shock. Multivariate Logistic regression analysis of early septic shock-related thrombocytopenia showed that, diabetes [odds ratio (OR) = 0.19, 95% confidence interval (95%CI) was 0.08-0.42, P < 0.001], urinary tract infection (OR = 0.33, 95%CI was 0.13-0.83, P = 0.018), G- bacilli infection (OR = 0.20, 95%CI was 0.07-0.58, P = 0.003), hyperlactic acidemia (OR = 1.25, 95%CI was 1.07-1.46, P = 0.005) and high APACHE II score (OR = 0.85, 95%CI was 0.78-0.92, P < 0.001) were independent risk factors for platelets < 50×109/L. Abdominal infection was an independent risk factor for PLT (50-100)×109/L (OR = 0.56, 95%CI was 0.34-0.95, P = 0.03). High SOFA score was an independent risk factor for PLT ≤ 100×109/L [PLT < 50×109/L: OR = 2.03, 95%CI was 1.65-2.52, P < 0.001; PLT (50-100)×109/L: OR = 1.31, 95%CI was 1.16-1.48, P < 0.001]. There were no significant differences in mechanical ventilation time, length of ICU stay, and in-hospital stay among the three groups (H values were 0.142, 2.134, and 3.990, respectively, all P > 0.05). The 28-day mortality of septic shock patients increased with the severity of thrombocytopenia (χ2 = 40.406, P < 0.001), and the 28-day mortality of severe thrombocytopenia group and mild thrombocytopenia group was significantly higher than those of the normal platelet group [66.7% (50/75), 43.1% (53/123) vs. 27.8% (80/288), both P < 0.05]. Kaplan-Meier survival curve analysis showed that the 28-day survival rate gradually decreased with the decrease of PLT, and the 28-day survival rate was higher in the normal platelet group (Log-Rank test: χ2 = 80.667, P < 0.001).
CONCLUSIONS: Diabetes, abdominal infection, urinary tract infection, G- bacilli infection, hyperlactic acidemia, high APACHE II score, and high SOFA score are independent risk factors for early septic shock-related thrombocytopenia. Early thrombocytopenia in patients with septic shock indicates a high risk of 28-day death.
参考来源
- Xu X, Wang H, Wu X, et al. [Risk factors of early septic shock-related thrombocytopenia and its impact on prognosis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34590560. doi:10.3760/cma.j.cn121430-20210112-00036
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。